O Benkert

Summary

Country: Germany

Publications

  1. ncbi An overview of the clinical efficacy of mirtazapine
    O Benkert
    Johannes Gutenberg University Mainz, Mainz, Germany
    Hum Psychopharmacol 17:S23-6. 2002
  2. ncbi Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder
    Otto Benkert
    PAS, Nurnberg, Germany
    J Clin Psychopharmacol 26:75-8. 2006
  3. ncbi Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers
    R Schlosser
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Str 8, D 55131, Mainz, Germany
    Psychoneuroendocrinology 25:377-88. 2000
  4. ncbi The primary care evaluation of mental disorders (PRIME-MD), German version: a comparison with the CIDI
    B Loerch
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Str 8, 55131, Mainz, Germany
    J Psychiatr Res 34:211-20. 2000
  5. ncbi Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale
    M J Muller
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Strasse 8, D 55131, Mainz, Germany
    J Affect Disord 60:137-40. 2000
  6. ncbi Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression
    Armin Szegedi
    Department of Psychiatry, University of Mainz, Mainz, Germany
    J Clin Psychiatry 64:413-20. 2003
  7. ncbi Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study
    Eugen Davids
    Department of Psychiatry University of Mainz, Mainz, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 26:1079-87. 2002
  8. ncbi Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia
    Matthias J Muller
    Department of Psychiatry, University of Mainz, Mainz, Germany
    J Clin Psychopharmacol 22:554-60. 2002

Collaborators

Detail Information

Publications8

  1. ncbi An overview of the clinical efficacy of mirtazapine
    O Benkert
    Johannes Gutenberg University Mainz, Mainz, Germany
    Hum Psychopharmacol 17:S23-6. 2002
    ..The negative predictive value approached maximum values as early as week 2 with mirtazapine and week 3 with paroxetine. This suggests that the predictability of the response to treatment is better with mirtazapine than with paroxetine...
  2. ncbi Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder
    Otto Benkert
    PAS, Nurnberg, Germany
    J Clin Psychopharmacol 26:75-8. 2006
    ..These results indicate that mirtazapine ODT has a faster onset of antidepressant efficacy than venlafaxine XR in patients with major depressive disorder, and that this effect is independent of its sleep-improving properties...
  3. ncbi Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers
    R Schlosser
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Str 8, D 55131, Mainz, Germany
    Psychoneuroendocrinology 25:377-88. 2000
    ....
  4. ncbi The primary care evaluation of mental disorders (PRIME-MD), German version: a comparison with the CIDI
    B Loerch
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Str 8, 55131, Mainz, Germany
    J Psychiatr Res 34:211-20. 2000
    ....
  5. ncbi Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale
    M J Muller
    Department of Psychiatry, University of Mainz, Untere Zahlbacher Strasse 8, D 55131, Mainz, Germany
    J Affect Disord 60:137-40. 2000
    ..Despite its importance, no distinction between moderate and severe depression using the Montgomery-Asberg Depression Rating Scale (MADRS) based on a direct comparison with the Hamilton Depression Rating Scale (HAMD-17) is available...
  6. ncbi Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression
    Armin Szegedi
    Department of Psychiatry, University of Mainz, Mainz, Germany
    J Clin Psychiatry 64:413-20. 2003
    ..We aimed to test whether early improvement under antidepressant treatment is a clinically useful predictor of later stable response and remission...
  7. ncbi Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study
    Eugen Davids
    Department of Psychiatry University of Mainz, Mainz, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 26:1079-87. 2002
    ..The presented method of analyzing syndrome profiles in a family study seems to be a possibility to demonstrate references to genetic links between patients and parents in anxiety- and alcohol-related disorders...
  8. ncbi Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia
    Matthias J Muller
    Department of Psychiatry, University of Mainz, Mainz, Germany
    J Clin Psychopharmacol 22:554-60. 2002
    ....